SLC30A8, CDKAL1, TCF7L2, KCNQ1 and IGF2BP2 are Associated with Type 2 Diabetes Mellitus in Iranian Patients

Código QR

SLC30A8, CDKAL1, TCF7L2, KCNQ1 and IGF2BP2 are Associated with Type 2 Diabetes Mellitus in Iranian Patients

Kazem Vatankhah Yazdi,1 Seyed Mehdi Kalantar,1 Massoud Houshmand,2,3 Masoud Rahmanian,4 Masoud Reza Manaviat,5 Mohammad Reza Jahani,6 Behnam Kamalidehghan,2,7 Amir Almasi-Hashiani8 1Department of Genetic, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran; 2Department of...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Vatankhah Yazdi K, Kalantar SM, Houshmand M, Rahmanian M, Manaviat MR, Jahani MR, Kamalidehghan B, Almasi-Hashiani A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	type 2 diabetes mellitus (t2dm) iranian populations the tetra amplification refractory mutation system (arms) the genome-wide association studies (gwas) pharmacogenetics and pharmacogenomic Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/4762a33987e3497b99b9651c77919c14
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Clinical applications of pharmacogenomics
por: Quiñones,Luis, et al.
Publicado: (2017)

Impact of Updating Pharmacogenetic Results: Lessons Learned from the PREDICT Program
por: Michelle Liu, et al.
Publicado: (2021)

Determinación del polimorfismo de CYP2C9*2 y su relación con la farmacocinética de acenocumarol en voluntarios sanos
por: Miranda,Carla, et al.
Publicado: (2011)

The pharmacogenomics journal
Publicado: (2001)

Objetivos moleculares para diseñar nuevos fármacos para el tratamiento de la diabetes tipo 2 y la obesidad
por: Bastarrachea,Raúl A, et al.
Publicado: (2008)

Transcription factor 7-like 2 (TCF7L2): a culprit gene in Type 2 Diabetes Mellitus
por: A. Jan, et al.
Publicado: (2021)

American journal of pharmacogenomics genomics-related research in drug development and clinical practice.
Publicado: (2001)

PREVALENCE OF POLYMORPHOUS LOCUS 681G>A OF CYP2C19 GENE IN RUSSIAN POPULATION
por: T. A. Bairova, et al.
Publicado: (2014)

Association Between CDKAL1, HHEX, CDKN2A/2B and IGF2BP2 Gene Polymorphisms and Susceptibility to Type 2 Diabetes in Uttarakhand, India
por: Verma AK, et al.
Publicado: (2021)

Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical Practice
por: Venkatachalapathy P, et al.
Publicado: (2021)

Transcriptome analysis of ABCB1, ABCG2 and the BCL2/BAX ratio in refractory and relapsed canine lymphomas under treatment and rescue protocol
por: Sirivisoot Sirintra, et al.
Publicado: (2018)

Personalized medicine of non-gene-specific chemotherapies for non-small cell lung cancer
por: Wenxiao Jiang, et al.
Publicado: (2021)

The Influence of CYP2D6 and CYP2C19 Genetic Variation on Diabetes Mellitus Risk in People Taking Antidepressants and Antipsychotics
por: Isabelle Austin-Zimmerman, et al.
Publicado: (2021)

Efecto de las variantes de VKORC1 y CYP2C9 sobre la dosis de anticoagulantes orales en individuos chilenos
por: Benavides,Felipe, et al.
Publicado: (2015)

Is Interferon α-2b 1 MillionIU/mL Truly Better Than Tacrolimus 0.03% for Steroid-Resistant VKC ?: Our 2-Year Experience at a Tertiary Health-Care Centre
por: Gupta S, et al.
Publicado: (2021)

Pharmacogenetic Aspects of Type 2 Diabetes Treatment
por: N. O. Pozdnyakov, et al.
Publicado: (2020)

ELECTROCATALYTIC REDUCTION OF CARBON DIOXIDE AT POLYMERIC COBALT TETRA (3-AMINO (PHENY1) PORPHYRIN GLASSY CARBON-MODIFIED ELECTRODES
por: RIQUELME,M.A., et al.
Publicado: (2003)

Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response
por: Jernström S, et al.
Publicado: (2017)

A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder
por: Caroul Chawar, et al.
Publicado: (2021)

The association of TCF7L2 rs7903146 polymorphism with type 2 diabetes mellitus among Tatars of Bashkortostan
por: Diana S. Avzaletdinova, et al.
Publicado: (2016)

SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues
por: Matteo D’Antonio, et al.
Publicado: (2021)

Molecular diagnosis & therapy
Publicado: (2006)

Age at onset of obesity, transcription factor 7-like 2 (TCF7L2) rs7903146 polymorphism, adiponectin levels and the risk of type 2 diabetes in obese patients
por: Małgorzata Wrzosek, et al.
Publicado: (2019)

Aplicaciones médicas de los descubrimientos genómicos
por: Cruz-Coke M,Ricardo
Publicado: (2001)

Farmacogenómica de los anticoagulantes orales: la importancia de establecer algoritmos de dosificación en población chilena
por: Guzmán,Neftalí, et al.
Publicado: (2020)

Association Between Single Nucleotide Polymorphisms in CDKAL1 and HHEX and Type 2 Diabetes in Chinese Population
por: Li C, et al.
Publicado: (2021)

MicroRNAs as Novel Biomarkers for P2Y12 – Inhibitors Resistance Prediction
por: Rytkin E, et al.
Publicado: (2021)

Genetic Variation of G6PD and CYP2D6: Clinical Implications on the Use of Primaquine for Elimination of Plasmodium vivax
por: Alexandra G. A. Stewart, et al.
Publicado: (2021)

Rs7903146 variant of TCF7L2 gene and rs18012824 variant of PPARG2 gene (Pro12Ala) are associated with type 2 diabetes mellitus in Novosibirsk population
por: Irina Arkad'evna Bondar', et al.
Publicado: (2013)

Pharmacogenetics
Publicado: (1991)

Interaction between dietary patterns and TCF7L2 polymorphisms on type 2 diabetes mellitus among Uyghur adults in Xinjiang Province, China
por: Cai J, et al.
Publicado: (2019)

Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy
por: Engel T, et al.
Publicado: (2021)

Association of polymorphic loci of susceptibility to diabetes mellitus type 2 in various ethnic groups of the Russian Federation
por: D. S. Avzaletdinova, et al.
Publicado: (2021)

Famacogénica del cáncer: Estudio de variaciones genéticamente determinadas en la susceptibilidad a cáncer por exposición a xenobióticos
por: Quiñones,Luis, et al.
Publicado: (2006)

Lack of association between KCNJ11 (rs5219) and ABCC8 (rs757110) polymorphisms and sulphonylurea treatment response in type 2 diabetes patients in Novosibirsk region
por: Irina Arkad'evna Bondar, et al.
Publicado: (2015)

Caracterización de la flexión y compresión de elementos estructurales huecos fabricados con láminas de Tetra Pak ® reciclado y cálculo aproximado de la huella de carbono producida en su elaboración
por: Quintero,M. L., et al.
Publicado: (2017)

Pharmacogenomic Testing and Patient Perception Inform Pain Pharmacotherapy
por: Feng-Hua Loh, et al.
Publicado: (2021)

Genetic Polymorphism of Drug Metabolic Gene CYPs, VKORC1, NAT2, DPYD and CHST3 of Five Ethnic Minorities in Heilongjiang Province, Northeast China
por: Zhang T, et al.
Publicado: (2021)

Pharmacogenetic Warfarin Dosing Algorithm in the Russian Population
por: T. A. Bairova, et al.
Publicado: (2019)

PRELIMINARY RESULTS OF THE REACTION OF CYCLOTRIMERIZATION OF PHENYLACETYLENE [2+2+2] CATALYZED BY [(Cp*)Co(Indene)] COMPLEX
por: Morales-Verdejo,Cesar, et al.
Publicado: (2018)